MDC Shares Medlab Clinical Limited

ASX

$0.01 — Prices as of close 2026-10-27

Last in our picks 2026-10-25 — not in the current list; analysis below is from that screen

Clinical-stage therapeutics provide asymmetric upside, though funding and development risks warrant limited sizing.

Future value: $0.01 (+60.00%) · 6-12 months

Signal breakdown

▸Pipeline milestones are the principal prospective share-price catalyst.

Is MDC a buy right now?

Our screen: WATCH (score 0) — Clinical-stage therapeutics provide asymmetric upside, though funding and development risks warrant limited sizing.

Computed from end-of-day data; not personal advice.

Our track record with MDC

First flagged in our daily picks as WATCH on 2026-10-25 at $0.01 — +0% since.

Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.

Related Health Care picks

CSL.AXCSL Limited PME.AXPro Medicus Limited COH.AXCochlear Limited RMD.AXResMed Inc.FPH.AXFisher & Paykel Health RHC.AXRamsay Health Care Lim NAN.AXNanosonics Limited SIG.AXSigma Healthcare Limit

Browse: all ASX stocks · Health Care picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.